<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">35677075</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>15</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2693-5015</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2022</Year><Month>Jun</Month><Day>07</Day></PubDate></JournalIssue><Title>Research square</Title><ISOAbbreviation>Res Sq</ISOAbbreviation></Journal><ArticleTitle>Metagenomic assessment of gut microbial communities and risk of severe COVID-19.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">rs.3.rs-1717624</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.21203/rs.3.rs-1717624/v1</ELocationID><Abstract><AbstractText>The gut microbiome is a critical modulator of host immunity and is linked to the immune response to respiratory viral infections. However, few studies have gone beyond describing broad compositional alterations in severe COVID-19, defined as acute respiratory or other organ failure. We profiled 127 hospitalized patients with COVID-19 (n=79 with severe COVID-19 and 48 with moderate) who collectively provided 241 stool samples from April 2020 to May 2021 to identify links between COVID-19 severity and gut microbial taxa, their biochemical pathways, and stool metabolites. 48 species were associated with severe disease after accounting for antibiotic use, age, sex, and various comorbidities. These included significant in-hospital depletions of Fusicatenibacter saccharivorans and Roseburia hominis, each previously linked to post-acute COVID syndrome or "long COVID", suggesting these microbes may serve as early biomarkers for the eventual development of long COVID. A random forest classifier achieved excellent performance when tasked with predicting whether stool was obtained from patients with severe vs. moderate COVID-19. Dedicated network analyses demonstrated fragile microbial ecology in severe disease, characterized by fracturing of clusters and reduced negative selection. We also observed shifts in predicted stool metabolite pools, implicating perturbed bile acid metabolism in severe disease. Here, we show that the gut microbiome differentiates individuals with a more severe disease course after infection with COVID-19 and offer several tractable and biologically plausible mechanisms through which gut microbial communities may influence COVID-19 disease course. Further studies are needed to validate these observations to better leverage the gut microbiome as a potential biomarker for disease severity and as a target for therapeutic intervention.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lai</LastName><ForeName>Peggy</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Massachusetts General Hospital, Harvard Medical School.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nguyen</LastName><ForeName>Long</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-5436-4219</Identifier><AffiliationInfo><Affiliation>Massachusetts General Hospital and Harvard Medical School.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Okin</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-3802-4695</Identifier><AffiliationInfo><Affiliation>Massachusetts General Hospital.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Drew</LastName><ForeName>David</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-8813-0816</Identifier><AffiliationInfo><Affiliation>Clinical and Translational Epidemiology Unit, Massachusetts General Hospital.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Battista</LastName><ForeName>Vincent</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Massachusetts General Hospital.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jesudasen</LastName><ForeName>Sirus</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Massachusetts General Hospital.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kuntz</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Harvard T.H. Chan School of Public Health.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bhosle</LastName><ForeName>Amrisha</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Harvard TH Chan School of Public Health.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thompson</LastName><ForeName>Kelsey</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Harvard T.H. Chan School of Public Health.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reinicke</LastName><ForeName>Trenton</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Massachusetts General Hospital.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lo</LastName><ForeName>Chun-Han</ForeName><Initials>CH</Initials><Identifier Source="ORCID">0000-0001-8202-4513</Identifier><AffiliationInfo><Affiliation>Massachusetts General Hospital and Harvard Medical School.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Woo</LastName><ForeName>Jacqueline</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Massachusetts General Hospital.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Caraballo</LastName><ForeName>Alexander</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Massachusetts General Hospital.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Berra</LastName><ForeName>Lorenzo</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Massachusetts General Hospital.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vieira</LastName><ForeName>Jacob</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Massachusetts General Hospital.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Ching-Ying</ForeName><Initials>CY</Initials><AffiliationInfo><Affiliation>Massachusetts General Hospital.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adhikari</LastName><ForeName>Upasana Das</ForeName><Initials>UD</Initials><AffiliationInfo><Affiliation>Massachusetts General Hospital.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Minsik</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Massachusetts General Hospital.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sui</LastName><ForeName>Hui-Yu</ForeName><Initials>HY</Initials><AffiliationInfo><Affiliation>Massachusetts General Hospital.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Magicheva-Gupta</LastName><ForeName>Marina</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Massachusetts General Hospital.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McIver</LastName><ForeName>Lauren</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Harvard T.H. Chan School of Public Health.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goldberg</LastName><ForeName>Marcia</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-4266-9733</Identifier><AffiliationInfo><Affiliation>Massachusetts General Hospital.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kwon</LastName><ForeName>Douglas</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0001-8521-8735</Identifier><AffiliationInfo><Affiliation>Harvard Medical School.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huttenhower</LastName><ForeName>Curtis</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-1110-0096</Identifier><AffiliationInfo><Affiliation>Harvard T.H. Chan School of Public Health.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chan</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Massachusetts General Hospital.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>K01 DK120742</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K23 DK125838</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 HL116275</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002541</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D000076942">Preprint</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>06</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Res Sq</MedlineTA><NlmUniqueID>101768035</NlmUniqueID><ISSNLinking>2693-5015</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="UpdateIn"><RefSource>Genome Med. 2023 Jul 12;15(1):49. doi: 10.1186/s13073-023-01202-6</RefSource><PMID Version="1">37438797</PMID></CommentsCorrections></CommentsCorrectionsList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>6</Month><Day>9</Day><Hour>2</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>6</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>6</Month><Day>10</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>6</Month><Day>8</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35677075</ArticleId><ArticleId IdType="pmc">PMC9176657</ArticleId><ArticleId IdType="doi">10.21203/rs.3.rs-1717624/v1</ArticleId><ArticleId IdType="pii">rs.3.rs-1717624</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Tracking. Johns Hopkins Coronavirus Resource Center
https://coronavirus.jhu.edu/data.</Citation></Reference><Reference><Citation>Lynch S. V. &amp; Pedersen O. The Human Intestinal Microbiome in Health and Disease. N. Engl. J. Med. 375, 2369&#x2013;2379 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">27974040</ArticleId></ArticleIdList></Reference><Reference><Citation>Keely S., Talley N. J. &amp; Hansbro P. M. Pulmonary-intestinal cross-talk in mucosal inflammatory disease. Mucosal Immunol. 5, 7&#x2013;18 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3243663</ArticleId><ArticleId IdType="pubmed">22089028</ArticleId></ArticleIdList></Reference><Reference><Citation>Bordon Y. Antibiotics can impede flu vaccines. Nature reviews. Immunology vol. 19 663 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31551570</ArticleId></ArticleIdList></Reference><Reference><Citation>Hagan T. et al. Antibiotics-Driven Gut Microbiome Perturbation Alters Immunity to Vaccines in Humans. Cell 178, 1313&#x2013;1328.e13 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6750738</ArticleId><ArticleId IdType="pubmed">31491384</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C.-J., Wu G.-H., Kuo R.-L. &amp; Shih S.-R. Role of the intestinal microbiota in the immunomodulation of influenza virus infection. Microbes Infect. 19, 570&#x2013;579 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28939355</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren Z. et al. Alterations in the human oral and gut microbiomes and lipidomics in COVID-19. Gut 70, 1253&#x2013;1265 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8042598</ArticleId><ArticleId IdType="pubmed">33789966</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang F. et al. Prolonged Impairment of Short-Chain Fatty Acid and L-Isoleucine Biosynthesis in Gut Microbiome in Patients With COVID-19. Gastroenterology 162, 548&#x2013;561.e4 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8529231</ArticleId><ArticleId IdType="pubmed">34687739</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo T. et al. Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization. Gastroenterology 159, 944&#x2013;955.e8 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7237927</ArticleId><ArticleId IdType="pubmed">32442562</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo T. et al. Depicting SARS-CoV-2 faecal viral activity in association with gut microbiota composition in patients with COVID-19. Gut 70, 276&#x2013;284 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7385744</ArticleId><ArticleId IdType="pubmed">32690600</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo T. et al. Alterations in Fecal Fungal Microbiome of Patients With COVID-19 During Time of Hospitalization until Discharge. Gastroenterology 159, 1302&#x2013;1310.e5 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7318920</ArticleId><ArticleId IdType="pubmed">32598884</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng S. C. et al. Gut microbiota composition is associated with SARS-CoV-2 vaccine immunogenicity and adverse events. Gut (2022) doi:10.1136/gutjnl-2021-326563.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2021-326563</ArticleId><ArticleId IdType="pmc">PMC8844967</ArticleId><ArticleId IdType="pubmed">35140064</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeoh Y. K. et al. Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19. Gut 70, 698&#x2013;706 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7804842</ArticleId><ArticleId IdType="pubmed">33431578</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu S. et al. Alterations of the Gut Microbiota in Patients With Coronavirus Disease 2019 or H1N1 Influenza. Clin. Infect. Dis. 71, 2669&#x2013;2678 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7314193</ArticleId><ArticleId IdType="pubmed">32497191</ArticleId></ArticleIdList></Reference><Reference><Citation>Schult D. et al. Gut bacterial dysbiosis and instability is associated with the onset of complications and mortality in COVID-19. Gut Microbes 14, 2031840 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8855857</ArticleId><ArticleId IdType="pubmed">35174781</ArticleId></ArticleIdList></Reference><Reference><Citation>Nashed L. et al. Gut microbiota changes are detected in asymptomatic very young children with SARS-CoV-2 infection. Gut (2022) doi:10.1136/gutjnl-2021-326599.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2021-326599</ArticleId><ArticleId IdType="pmc">PMC9357857</ArticleId><ArticleId IdType="pubmed">35135843</ArticleId></ArticleIdList></Reference><Reference><Citation>Newsome R. C. et al. The gut microbiome of COVID-19 recovered patients returns to uninfected status in a minority-dominated United States cohort. Gut Microbes 13, 1&#x2013;15 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8205023</ArticleId><ArticleId IdType="pubmed">34100340</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Q. et al. Gut microbiota dynamics in a prospective cohort of patients with post-acute COVID-19 syndrome. Gut 71, 544&#x2013;552 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35082169</ArticleId></ArticleIdList></Reference><Reference><Citation>Nonhospitalized adults: Therapeutic management. COVID-19 Treatment Guidelines
https://www.covid19treatmentguidelines.nih.gov/management/clinical-management/nonhospitalized-adults--therapeutic-management/.</Citation></Reference><Reference><Citation>Zhou Y., Zhang J., Zhang D., Ma W.-L. &amp; Wang X. Linking the gut microbiota to persistent symptoms in survivors of COVID-19 after discharge. J. Microbiol. 59, 941&#x2013;948 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8356893</ArticleId><ArticleId IdType="pubmed">34382150</ArticleId></ArticleIdList></Reference><Reference><Citation>Berlin D. A., Gulick R. M. &amp; Martinez F. J. Severe Covid-19. N. Engl. J. Med. 383, 2451&#x2013;2460 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32412710</ArticleId></ArticleIdList></Reference><Reference><Citation>Gall J.-R. L. &amp; Le Gall J.-R. A New Simplified Acute Physiology Score (SAPS II) Based on a European/North American Multicenter Study. JAMA: The Journal of the American Medical Association vol. 270 2957 (1993).</Citation><ArticleIdList><ArticleId IdType="pubmed">8254858</ArticleId></ArticleIdList></Reference><Reference><Citation>Vincent J. L. et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med. 22, 707&#x2013;710 (1996).</Citation><ArticleIdList><ArticleId IdType="pubmed">8844239</ArticleId></ArticleIdList></Reference><Reference><Citation>Beck D. H., Smith G. B., Pappachan J. V. &amp; Millar B. External validation of the SAPS II, APACHE II and APACHE III prognostic models in South England: a multicentre study. Intensive Care Med. 29, 249&#x2013;256 (2003).</Citation><ArticleIdList><ArticleId IdType="pubmed">12536271</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferreira F. L., Bota D. P, Bross A., M&#xe9;lot C. &amp; Vincent J. L. Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA 286, 1754&#x2013;1758 (2001).</Citation><ArticleIdList><ArticleId IdType="pubmed">11594901</ArticleId></ArticleIdList></Reference><Reference><Citation>Rand W. M. Objective Criteria for the Evaluation of Clustering Methods. J. Am. Stat. Assoc. 66, 846&#x2013;850 (1971).</Citation></Reference><Reference><Citation>Qannari E. M., Courcoux P. &amp; Faye P. Significance test of the adjusted Rand index. Application to the free sorting task. Food Qual. Prefer. 32, 93&#x2013;97 (2014).</Citation></Reference><Reference><Citation>Real R. &amp; Vargas J. M. The Probabilistic Basis of Jaccard&#x2019;s Index of Similarity. Syst. Biol. 45, 380&#x2013;385 (1996).</Citation></Reference><Reference><Citation>Mallick H. et al. Predictive metabolomic profiling of microbial communities using amplicon or metagenomic sequences. Nat. Commun. 10, 3136 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6637180</ArticleId><ArticleId IdType="pubmed">31316056</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen B. et al. Proteomic and Metabolomic Characterization of COVID-19 Patient Sera. Cell 182, 59&#x2013;72.e15 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7254001</ArticleId><ArticleId IdType="pubmed">32492406</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas T. et al. COVID-19 infection alters kynurenine and fatty acid metabolism, correlating with IL-6 levels and renal status. JCI Insight 5, (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7453907</ArticleId><ArticleId IdType="pubmed">32559180</ArticleId></ArticleIdList></Reference><Reference><Citation>Lv L. et al. The faecal metabolome in COVID-19 patients is altered and associated with clinical features and gut microbes. Anal. Chim. Acta 1152, 338267 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7847702</ArticleId><ArticleId IdType="pubmed">33648648</ArticleId></ArticleIdList></Reference><Reference><Citation>Gallo Marin B. et al. Predictors of COVID-19 severity: A literature review. Rev. Med. Virol. 31, 1&#x2013;10 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7855377</ArticleId><ArticleId IdType="pubmed">32845042</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabaro S. et al. Cytokine signature and COVID-19 prediction models in the two waves of pandemics. Sci. Rep. 11, 20793 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8531346</ArticleId><ArticleId IdType="pubmed">34675240</ArticleId></ArticleIdList></Reference><Reference><Citation>Raschke R. A., Agarwal S., Rangan P., Heise C. W. &amp; Curry S. C. Discriminant Accuracy of the SOFA Score for Determining the Probable Mortality of Patients With COVID-19 Pneumonia Requiring Mechanical Ventilation. JAMA 325, 1469&#x2013;1470 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7890534</ArticleId><ArticleId IdType="pubmed">33595630</ArticleId></ArticleIdList></Reference><Reference><Citation>Peeling R. W., Heymann D. L., Teo Y.-Y. &amp; Garcia P. J. Diagnostics for COVID-19: moving from pandemic response to control. Lancet 399, 757&#x2013;768 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8687671</ArticleId><ArticleId IdType="pubmed">34942102</ArticleId></ArticleIdList></Reference><Reference><Citation>Vacca M. et al. The Controversial Role of Human Gut Lachnospiraceae. Microorganisms vol. 8 573 (2020)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7232163</ArticleId><ArticleId IdType="pubmed">32326636</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen M. L., Takeda K. &amp; Sundrud M. S. Emerging roles of bile acids in mucosal immunity and inflammation. Mucosal Immunol. 12, 851&#x2013;861 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">30952999</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawamata Y. et al. A G Protein-coupled Receptor Responsive to Bile Acids *. J. Biol. Chem. 278, 9435&#x2013;9440 (2003).</Citation><ArticleIdList><ArticleId IdType="pubmed">12524422</ArticleId></ArticleIdList></Reference><Reference><Citation>Hao H. et al. Farnesoid X Receptor Regulation of the NLRP3 Inflammasome Underlies Cholestasis-Associated Sepsis. Cell Metab. 25, 856&#x2013;867.e5 (2017)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6624427</ArticleId><ArticleId IdType="pubmed">28380377</ArticleId></ArticleIdList></Reference><Reference><Citation>Ichinohe T. et al. Microbiota regulates immune defense against respiratory tract influenza A virus infection. Proc. Natl. Acad. Sci. U. S. A. 108, 5354&#x2013;5359 (2011)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3069176</ArticleId><ArticleId IdType="pubmed">21402903</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefan K. L., Kim M. V., Iwasaki A. &amp; Kasper D. L. Commensal Microbiota Modulation of Natural Resistance to Virus Infection. Cell 183, 1312&#x2013;1324.e10 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7799371</ArticleId><ArticleId IdType="pubmed">33212011</ArticleId></ArticleIdList></Reference><Reference><Citation>Li T. &amp; Chiang J. Y. L. Nuclear receptors in bile acid metabolism. Drug Metab. Rev. 45, 145&#x2013;155 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3676171</ArticleId><ArticleId IdType="pubmed">23330546</ArticleId></ArticleIdList></Reference><Reference><Citation>Makishima M. et al. Vitamin D receptor as an intestinal bile acid sensor. Science 296, 1313&#x2013;1316 (2002).</Citation><ArticleIdList><ArticleId IdType="pubmed">12016314</ArticleId></ArticleIdList></Reference><Reference><Citation>Staudinger J. L. et al. The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity. Proc. Natl. Acad. Sci. U. S. A. 98, 3369&#x2013;3374 (2001).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC30660</ArticleId><ArticleId IdType="pubmed">11248085</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiu Z. et al. Pregnane X Receptor Regulates Pathogen-Induced Inflammation and Host Defense against an Intracellular Bacterial Infection through Toll-like Receptor 4. Sci. Rep. 6, 31936 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4994038</ArticleId><ArticleId IdType="pubmed">27550658</ArticleId></ArticleIdList></Reference><Reference><Citation>Kongsbak M., Levring T. B., Geisler C. &amp; von Essen M. R. The vitamin d receptor and T cell function. Front. Immunol. 4, 148 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3684798</ArticleId><ArticleId IdType="pubmed">23785369</ArticleId></ArticleIdList></Reference><Reference><Citation>Merino J. et al. Diet quality and risk and severity of COVID-19: a prospective cohort study. Gut 70, 2096&#x2013;2104 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8500931</ArticleId><ArticleId IdType="pubmed">34489306</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma W. et al. Associations between predicted vitamin D status, vitamin D intake, and risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and coronavirus disease 2019 (COVID-19) severity. Am. J. Clin. Nutr. 115, 1123&#x2013;1133 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8690242</ArticleId><ArticleId IdType="pubmed">34864844</ArticleId></ArticleIdList></Reference><Reference><Citation>Stutz M. R. et al. Association of Fecal Microbiota Composition and Function with Progression of Respiratory Failure and Death in Patients with COVID-19 Critical Illness. in D94. PANDEMIC OUTPUT: ALL THAT IS COVID-19 A5289-A5289 (American Thoracic Society, 2022). doi:10.1164/ajrccm-conference.2022.205.1_MeetingAbstracts.A5289.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/ajrccm-conference.2022.205.1_MeetingAbstracts.A5289</ArticleId></ArticleIdList></Reference><Reference><Citation>Corum J. &amp; Zimmer C. Tracking Omicron and Other Coronavirus Variants. The New York Times (2021).</Citation></Reference><Reference><Citation>Sundararajan V. et al. New ICD-10 version of the Charlson comorbidity index predicted in-hospital mortality. J. Clin. Epidemiol. 57, 1288&#x2013;1294 (2004).</Citation><ArticleIdList><ArticleId IdType="pubmed">15617955</ArticleId></ArticleIdList></Reference><Reference><Citation>Sui H.-Y. et al. Impact of DNA Extraction Method on Variation in Human and Built Environment Microbial Community and Functional Profiles Assessed by Shotgun Metagenomics Sequencing. Front. Microbiol. 11, 953 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7262970</ArticleId><ArticleId IdType="pubmed">32528434</ArticleId></ArticleIdList></Reference><Reference><Citation>CDC. Labs. Centers for Disease Control and Prevention; 
https://www.cdc.gov/coronavirus/2019-ncov/lab/rt-pcr-panel-primer-probes.html.</Citation></Reference><Reference><Citation>McIver L. J. et al. bioBakery: a meta&#x2019;omic analysis environment. Bioinformatics 34, 1235&#x2013;1237 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6030947</ArticleId><ArticleId IdType="pubmed">29194469</ArticleId></ArticleIdList></Reference><Reference><Citation>Beghini F. et al. Integrating taxonomic, functional, and strain-level profiling of diverse microbial communities with bioBakery 3. Elife 10, (2021)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8096432</ArticleId><ArticleId IdType="pubmed">33944776</ArticleId></ArticleIdList></Reference><Reference><Citation>Caspi R. et al. The MetaCyc database of metabolic pathways and enzymes and the BioCyc collection of Pathway/Genome Databases. Nucleic Acids Res. 42, D459&#x2013;71 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3964957</ArticleId><ArticleId IdType="pubmed">24225315</ArticleId></ArticleIdList></Reference><Reference><Citation>Chong J. &amp; Xia J. Computational Approaches for Integrative Analysis of the Metabolome and Microbiome. Metabolites 7, (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5746742</ArticleId><ArticleId IdType="pubmed">29156542</ArticleId></ArticleIdList></Reference><Reference><Citation>Wirbel J. et al. Microbiome meta-analysis and cross-disease comparison enabled by the SIAMCAT machine learning toolbox. Genome Biol. 22, 93 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8008609</ArticleId><ArticleId IdType="pubmed">33785070</ArticleId></ArticleIdList></Reference><Reference><Citation>Peschel S., M&#xfc;ller C. L., von Mutius E., Boulesteix A.-L. &amp; Depner M. NetCoMi: network construction and comparison for microbiome data in R. Brief. Bioinform. 22, (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8293835</ArticleId><ArticleId IdType="pubmed">33264391</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>